Skip to main content

Table 3 Correlation of hippocampal dosimetry with the status of NCF change in verbal memory after HS-WBRT

From: Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study

Dosimetric parameters

Dosimetric cut-off points

NCF Preservation N (%)

No preservation

p value

Bilateral hippocampi as a composite structure

Maximum

≤12.6 Gy

10(83.3 %)

2(16.7 %)

0.004*

>12.6 Gy

3(25.0 %)

9(75.0 %)

 D10%

≤8.81 Gy

9(75.0 %)

3(25.0 %)

0.041*

>8.81 Gy

4(33.3 %)

8(66.7 %)

 D20%

≤8.26 Gy

8(66.7 %)

4(33.3 %)

0.219

>8.26 Gy

5(41.7 %)

7(58.3 %)

 D30%

≤7.95 Gy

8(66.7 %)

4(33.3 %)

0.219

>7.95 Gy

5(41.7 %)

7(58.3 %)

 D40%

≤7.68 Gy

8(66.7 %)

4(33.3 %)

0.219

>7.68 Gy

5(41.7 %)

7(58.3 %)

 D50%

≤7.45 Gy

9(75.0 %)

3(25.0 %)

0.041*

>7.45 Gy

4(33.3 %)

8(66.7 %)

 D80%

≤6.80 Gy

9(75.0 %)

3(25.0 %)

0.041*

>6.80 Gy

4(33.3 %)

8(66.7 %)

 D100%

≤5.83 Gy

9(75.0 %)

3(25.0 %)

0.041*

>5.83 Gy

4(33.3 %)

8(66.7 %)

Left hippocampus

Maximum

≤12.41 Gy

10(83.3 %)

2(16.7 %)

0.004*

>12.41 Gy

3(25.0 %)

9(75.0 %)

 D10%

≤8.75 Gy

9(75.0 %)

3(25.0 %)

0.041*

>8.75 Gy

4(33.3 %)

8(66.7 %)

 D20%

≤8.22 Gy

8(66.7 %)

4(33.3 %)

0.219

>8.22 Gy

5(41.7 %)

7(58.3 %)

 D30%

≤7.94 Gy

8(66.7 %)

4(33.3 %)

0.219

>7.94 Gy

5(41.7 %)

7(58.3 %)

 D40%

≤7.70 Gy

9(75.0 %)

3(25.0 %)

0.041*

>7.70 Gy

4(33.3 %)

8(66.7 %)

 D50%

≤7.48 Gy

9(75.0 %)

3(25.0 %)

0.041*

>7.48 Gy

4(33.3 %)

8(66.7 %)

 D80%

≤6.73 Gy

9(75.0 %)

3(25.0 %)

0.041*

>6.73 Gy

4(33.3 %)

8(66.7 %)

 D100%

≤5.73 Gy

8(66.7 %)

4(33.3 %)

0.219

>5.73 Gy

5(41.7 %)

7(58.3 %)

 
  1. The status of neurocognitive change shown here is according to patients’ performance on the immediate recall of Wechsler Memory Scale-III Word Lists. The association between hippocampal dosimetry and the status of NCF change (preservation or not) in verbal memory 4 months after the HS-WBRT course was evaluated by using chi-square test for the 24 patients in whom post-treatment NCF assessment was available
  2. The N (%) is listed to stand for the number of patients and its corresponding percentage
  3. * indicates that statistical significance is noted